Dr. David A. Khan Named Next AAAAI Executive Vice President

The American Academy of Allergy, Asthma & Immunology (AAAAI) has announced that David A. Khan, MD, FAAAAI, will take on the role of Executive Vice President starting in January 2027. According to the organization, Dr. Khan's appointment marks a new chapter for the leadership of the specialty membership organization.

Leadership Background and Transition

Dr. Khan is scheduled to assume his duties in January 2027, temporarily overlapping with retiring Executive Vice President Thomas Fleisher, MD, FAAAAI, until the conclusion of the 2027 AAAAI Annual Meeting. His extensive history with the organization includes serving as AAAAI President from 2022 to 2023, chairing the AAAAI Foundation Council from 2023 to 2024, and holding numerous other committee and leadership positions.

• Served as AAAAI President (2022–2023)
• Former Chair of the AAAAI Foundation Council
• Longtime member of the Joint Task Force on Practice Parameters

Current Professional Roles

Outside of his organizational involvement, Dr. Khan maintains academic and clinical positions. He serves as a program director and Professor of Medicine and Pediatrics at UT Southwestern. Additionally, he works as an Associate Editor for The Journal of Allergy and Clinical Immunology: In Practice.

Practical Implications and Verification

• Members and healthcare professionals can monitor official communications for transition updates.
• Verification of leadership announcements and organizational updates can be conducted directly through the official AAAAI website at aaaai.org.